Cardiology: An International Perspective

Front Matter....Pages i-xxii
Front Matter....Pages 1-1
Are There Markers for the Physiopathology of Essential Hypertension?....Pages 3-12
Control and Treatment of Arterial Hypertension....Pages 13-31
Biochemical Mechanisms of Altered Metabolism in Ischemic Heart....Pages 33-43
Calcium and Cardiovascular Disease....Pages 45-51
Cellular and Molecular Mechanisms of Atherosclerosis....Pages 53-70
Coronary Artery Disease in Children....Pages 71-81
Cardiomyopathies: Pathology and Infectious Immune Mechanisms....Pages 83-90
Treatment of Cardiomyopathies....Pages 91-105
Heart in Outer Space....Pages 107-116
Progress in Radionuclide Methods....Pages 117-139
Clinical Trials with Antiaggregating Agents in Thrombosis....Pages 141-152
Echocardiography: Present State of the Art....Pages 153-164
High Blood Cholesterol and High Blood Pressure: State of Knowledge Today and Implications for Prevention and Control of Epidemic Adult Cardiovascular Disease....Pages 165-186
Detection and Treatment of Ventricular Arrhythmias....Pages 187-192
Clinical Efficiency and Side-Effects of Old and New Antiarrhythmic Drugs....Pages 193-207
General and Local Factors in Arterial Thrombosis: Platelets, Prostaglandins and Postulates....Pages 209-216
Front Matter....Pages 217-217
Influence of Different Factors on Mild Hypertension....Pages 219-227
Epidemiology and Natural Process of Mild Hypertension....Pages 229-233
Mild Hypertension : Treatment and Prognosis....Pages 235-237
Antihypertensive Therapy in Patients Above Age 60: A report of the European Working Party on High Blood Pressure in the Elderly (EWPHE)....Pages 239-240
Front Matter....Pages 217-217
High Density Lipoproteins and Atherosclerosis....Pages 337-346
Regulation of Plasma High Density Lipoprotein Concentration by Lipoprotein Lipase and Hepatic Endothelial Lipase....Pages 347-354
Peculiarities of Composition and Properties of High-Density Lipoproteins in Patients with Coronary Atherosclerosis....Pages 355-360
Blood Lipids and Antihypertensive Drugs: The Oslo Study....Pages 361-363
Endogenous Regulation of Prostacyclin Synthesis in Arterial Smooth Muscle Cells....Pages 365-371
Platelets, Megakaryocytes and Vascular Disease....Pages 373-384
Effects of Beta Receptor Blocking Drugs on Prostacyclin (PGI 2 ) and Thromboxane A 2 (TXA 2 ) Biosynthesis as a New Aspect of their Mode of Action....Pages 385-389
Platelet Spreading and Thrombi-Formation in Vitro ....Pages 391-409
Impairment of Fibrinolysis as a Risk Factor for Thrombosis....Pages 411-415
Blood Tests for the Diagnosis of Thromboembolism....Pages 417-422
The Clinical Relevance of Partial Agonist Activity of Beta-Adrenoceptor Blocking Drugs....Pages 241-252
The Withdrawal of Beta Adrenergic Blocking Drugs....Pages 253-267
The Management of Hypertension....Pages 269-271
Sodium and Blood Pressure in Human Hypertension....Pages 273-281
Inhibition of the Renin Angiotensin System in the Treatment of Hypertension....Pages 283-287
Catheter Treatment of Renovascular Hypertension....Pages 289-295
Pathogenetic Mechanisms in Essential Hypertension....Pages 297-307
Neural Factors in Essential Hypertension....Pages 309-318
Renovascular Hypertension: New Aspects of Pathogenesis and Treatment....Pages 319-326
Alteration of Cell Membranes in Primary Hypertension....Pages 327-336
Front Matter....Pages 217-217
Intervention Trials — Problems of International Coordination and Evaluation....Pages 597-600
Hypertension Control in Populations....Pages 601-606
Epidemiology of Sudden Cardiac Death....Pages 459-465
Neural Factors in Sudden Death....Pages 467-471
Management of the Patient at High Risk for Sudden Cardiac Death....Pages 473-486
Substrate Effects in Myocardial Ischemia....Pages 547-550
Prevention of Catecholamine-Induced Myocardial Damage....Pages 551-560
Maintenance of Ca 2+ Homeostasis in the Myocardium....Pages 561-567
Theoretical Implications of the use of Antioxidants for Heart Protection Against Stress-Induced and Ischemic Damages....Pages 569-582
Nuclear Magnetic Resonance Studies of Intracellular pH and Myocardial Contractility during Ischemia....Pages 583-595
Stroke and Cardiac Disorders....Pages 487-493
The Pathogenesis of Vascular Disorders of Brain and Heart — Are There Similarities or Dissimilarities?....Pages 495-501
Atherosclerosis and Thrombosis of the Cerebral and Coronary Arteries....Pages 503-507
Manifestations of Coronary Disease Predisposing to Stroke: The Framingham Study....Pages 509-515
Limitation of Infarct Size: Theoretical Aspects....Pages 517-523
Quantitative Assessment of Infarct Size and its Influence by Thrombolysis....Pages 525-533
Limitation of Infarct Size by Pharmacological Interventions....Pages 535-546
Heart Microcirculation....Pages 423-429
Dynamic Coronary Stenosis: The Elusive Link between Coronary Atherosclerosis and Clinical Manifestations of Ischaemic Heart Disease....Pages 431-450
Fate of the Coronary Microvasculature in Infarcting Canine Myocardium: Role of Collateral Blood Flow....Pages 451-458
Front Matter....Pages 217-217
Comprehensive Cardiovascular Community Control Program in the Philippines....Pages 607-609
Prevention of Cardiovascular Diseases WHO Programme....Pages 611-615
Integrated Prevention Within Primary Health Care....Pages 617-620
Multiple Risk Factor Intervention Trial: 6 Year Risk Factor Changes....Pages 621-626
Multifactor Prevention of Ischemic Heart Disease (A Cooperative Survey)....Pages 627-634
Effect of Diet and Smoking Intervention on the Incidence of Coronary Heart Disease....Pages 635-641
The Present Status of Cardiovascular Medicine in Africa....Pages 643-648
Chagas’ Cardiomyopathy....Pages 649-656
Cardiovascular Disease in Developing Countries Rheumatic Heart Disease....Pages 657-670
Long-Term Results of Coronary Rehabilitation: Rationale, Implementation and Significance of Programs....Pages 671-676
Long-Term Results of Coronary Rehabilitation: Factors and Reasons for Success and Failure....Pages 677-680
The Economic Effects of Cardiac Rehabilitation: Principles, Methods and Problems of Evaluation....Pages 681-688